Chiral metallocene compounds and preparation thereof by creation of a chiral center by enantioselective hydride transfer

Claim 1

A method of making enantiomcrically enhanced chiral optionally substituted cyclopentadienyl ligand represented by the general formula III: ##STR10## comprising contacting an optionally substituted fulvene having a prochiral carbon at the carbon 6 position represented by the general formula 1: ##STR11## with a lithium salt under suitable reaction conditions so as to form the enantiomerically enhanced cyciopentadienyl ligand of general formula lII, wherein C* is a chiral carbon center: each R is independently selected from the group consisting of H or C 1-12 substituted aliphatic, unsubstituted aliphatic, substituted cyclic, unsubstituted cyclic, substituted heterocyclic, and unsubstituted heterocyclic radicals or two neighboring R groups are joined to provide a ring of five or more carbon atoms; R 1 and R 2 are not the same and are each independently selected from the group consisting of II or a C 1-8 substituted aliphatic, unsubstituted aliphatic, substituted cyclic, unsubstituted cyclic, substituted heterocyclic, and unsubstituted heterocyclic radicals; and the lithium salt is a lithium salt of at least one selected from the group consisting of chiral amines, chiral amides, and chiral amino acids, all of which have a hydrogen on a carbon alpha to the nitrogen, wherein the chiral amines are selected from the group or chiral primary and secondary cyclic, acyclic, heterocyclic, open chain and functionalized amines, and the chiral amide are selected from the group consisting of chiral cyclic, acyclic, and heterocyclic amides.

Claim 2

A method of making enantiomcrically enhanced chiral optionally substituted cyclopentadienyl ligand represented by the general formula III: ##STR10## comprising contacting an optionally substituted fulvene having a prochiral carbon at the carbon 6 position represented by the general formula 1: ##STR11## with a lithium salt under suitable reaction conditions so as to form the enantiomerically enhanced cyciopentadienyl ligand of general formula lII, wherein C* is a chiral carbon center: each R is independently selected from the group consisting of H or C 1-12 substituted aliphatic, unsubstituted aliphatic, substituted cyclic, unsubstituted cyclic, substituted heterocyclic, and unsubstituted heterocyclic radicals or two neighboring R groups are joined to provide a ring of five or more carbon atoms; R 1 and R 2 are not the same and are each independently selected from the group consisting of II or a C 1-8 substituted aliphatic, unsubstituted aliphatic, substituted cyclic, unsubstituted cyclic, substituted heterocyclic, and unsubstituted heterocyclic radicals; and the lithium salt is a lithium salt of at least one selected from the group consisting of chiral amines, chiral amides, and chiral amino acids, all of which have a hydrogen on a carbon alpha to the nitrogen, wherein the chiral amines are selected from the group or chiral primary and secondary cyclic, acyclic, heterocyclic, open chain and functionalized amines, and the chiral amide are selected from the group consisting of chiral cyclic, acyclic, and heterocyclic amides.

Claim 16

A method of making enantionmerically enhanced chiral optionally substituted cyclopentadienyl ligands of general formula III: ##STR12## comprising contacting an optionally substituted fulvene having a prochiral carbon at the carbon 6 position of general formula I: ##STR13## with a lithium salt under suitable reaction conditions so as to form the enantiomerically enhanced cyclopentadienyl ligand of general formula III at an enantiomeric excess of at least 5 percent; wherein C* is a chiral carbon center; each R is independently selected from the group consisting of H or a C 1-12 substituted aliphatic, unsubstituted aliphatic, substituted cyclic, unsubstituted cyclic, substituted heterocyclic, and unsubstituted heterocyclic radicals or two neighboring R groups are joined to provide a ring of five or more carbon atoms or each R is independently selected from the group consisting of H, methyl, ethyl, and propyl R 1 and R 2 are not the same and are each independently selected from the group consisting of H or a C 1-8 substituted aliphatic, unsubstituted aliphatic, substituted cyclic, unsubstituted cyclic, substituted heterocyclic, and unsubstituted heterocyclic radicals: and the lithium salt is a lithium salt of at least one selected from the group consisting of chiral amincs, chiral amides, and chiral amino acids, all of which have a hydrogen on a carbon alpha to the nitrogen, wherein the chiral amines are selected from the group consisting of chiral primary and second acyclic, acyclic, heterocyclic, open chain and functionalized amines, and the chiral amides are selected from the group consisting of chiral cyclic, acyclic, and heterocyclic amides; the fulvene and the lithium salt are contacted together at a temperature in the range of about -78° to -50° C., at a pressure in the range of about 0 to about 16 psig, for a contacting time in the range ofabout 1 to about 8 hours, and at a mole ratio of fulvene to lithium salt in the range of about 1.1 to 1 to about 1 to 1; the fulvene is selected from the group consisting of 6-methyl-6-phenylfulvene, 6-methyl-6-ethylfulvene, 6-methyl-6-propylfulvene, 6-ethyl-6-propylfulvene, 6-ethyl-6-phenyifulvene, and 6proyl-6-phenylfulvene; the substituted fulvene and the lithium salt are contacted together in the presence of a solvent selected from the group consisting of ethers, hydrocarbons, aromatic hydrocarbons and mixtures thereof; and the lithium salt is selected from the group consisting of the lithium salt of 2-methylindoline, the dilithium salt of(s)-(-)-2-pyrrolidone-5-carboxylic acid and the dilithium salt of L proline.

Claim 17

A method of making enantionmerically enhanced chiral optionally substituted cyclopentadienyl ligands of general formula III: ##STR12## comprising contacting an optionally substituted fulvene having a prochiral carbon at the carbon 6 position of general formula I: ##STR13## with a lithium salt under suitable reaction conditions so as to form the enantiomerically enhanced cyclopentadienyl ligand of general formula III at an enantiomeric excess of at least 5 percent; wherein C* is a chiral carbon center; each R is independently selected from the group consisting of H or a C 1-12 substituted aliphatic, unsubstituted aliphatic, substituted cyclic, unsubstituted cyclic, substituted heterocyclic, and unsubstituted heterocyclic radicals or two neighboring R groups are joined to provide a ring of five or more carbon atoms or each R is independently selected from the group consisting of H, methyl, ethyl, and propyl R 1 and R 2 are not the same and are each independently selected from the group consisting of H or a C 1-8 substituted aliphatic, unsubstituted aliphatic, substituted cyclic, unsubstituted cyclic, substituted heterocyclic, and unsubstituted heterocyclic radicals: and the lithium salt is a lithium salt of at least one selected from the group consisting of chiral amincs, chiral amides, and chiral amino acids, all of which have a hydrogen on a carbon alpha to the nitrogen, wherein the chiral amines are selected from the group consisting of chiral primary and second acyclic, acyclic, heterocyclic, open chain and functionalized amines, and the chiral amides are selected from the group consisting of chiral cyclic, acyclic, and heterocyclic amides; the fulvene and the lithium salt are contacted together at a temperature in the range of about -78° to -50° C., at a pressure in the range of about 0 to about 16 psig, for a contacting time in the range ofabout 1 to about 8 hours, and at a mole ratio of fulvene to lithium salt in the range of about 1.1 to 1 to about 1 to 1; the fulvene is selected from the group consisting of 6-methyl-6-phenylfulvene, 6-methyl-6-ethylfulvene, 6-methyl-6-propylfulvene, 6-ethyl-6-propylfulvene, 6-ethyl-6-phenyifulvene, and 6proyl-6-phenylfulvene; the substituted fulvene and the lithium salt are contacted together in the presence of a solvent selected from the group consisting of ethers, hydrocarbons, aromatic hydrocarbons and mixtures thereof; and the lithium salt is selected from the group consisting of the lithium salt of 2-methylindoline, the dilithium salt of(s)-(-)-2-pyrrolidone-5-carboxylic acid and the dilithium salt of L proline.